FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular to ophthalmology, and can be used to detect an active destructive process in the retina in an experiment. The method includes determining the activity of alpha2-macroglobulin (α2-MG) in the lacrimal fluid of a rabbit. If the value of α2-MG is more than 6.00 nmol/min×ml, an active destructive process is detected.
EFFECT: use of the invention provides the possibility of non-invasive evaluation of metabolic disorders, reflecting the active destructive process in the retina in dynamics.
1 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR EARLY DIAGNOSIS OF PARKINSON'S DISEASE | 2019 |
|
RU2722666C1 |
| METHOD FOR DETERMINING INDICATIONS FOR ACTIVE ANTI-INFLAMMATORY THERAPY BEFORE PERFORMING OPTO-RECONSTRUCTIVE OPERATIONS IN CHILDREN WITH ENDOGENOUS UVEITIS | 2022 |
|
RU2782132C1 |
| METHOD OF EXPERIMENTAL TREATMENT OF EYE NEURODEGENERATIVE PROCESS | 2023 |
|
RU2794835C1 |
| METHOD FOR PREVENTING EROSION AND ULCERATION OF CORNEA IN THE CASES OF BILATERAL EYE BURNS | 2001 |
|
RU2198635C1 |
| METHOD OF SIMULATING RETINAL PIGMENT EPITHELIUM ATROPHY | 2019 |
|
RU2709247C1 |
| METHOD OF TRANSPLANTATION OF RETINAL PIGMENT EPITHELIUM (RPE) CELLS DIFFERENTIATED FROM INDUCED HUMAN PLURIPOTENT STEM CELLS, WITH RETINAL PIGMENT EPITHELIUM ATROPHY | 2019 |
|
RU2730937C1 |
| METHOD OF SUBRETINAL TRANSPLANTATION OF RETINAL PIGMENT EPITHELIUM (RPE) CELLS DIFFERENTIATED FROM HUMAN INDUCED PLURIPOTENT STEM CELLS, WITH ATROPHY OF RETINAL PIGMENT EPITHELIUM IN EXPERIMENT | 2019 |
|
RU2729937C1 |
| METHOD FOR TREATMENT AND PROPHYLAXIS OF OPHTHALMIC DISEASE ASSOCIATED WITH EYE TISSUE ISCHEMIA | 2004 |
|
RU2268722C2 |
| METHOD FOR THE TREATMENT OF PROLIFERATIVE PROCESSES OF THE POSTERIOR SEGMENT OF THE EYE | 2018 |
|
RU2684927C1 |
| METHOD FOR PREDICTING CORNEAL SUBEPITHELIAL FIBROPLASIA DEVELOPMENT AFTER PHOTOREFRACTIVE EXCIMER LASER KERATECTOMY | 2005 |
|
RU2291429C1 |
